HNF recognizes that improving the future for those with Charcot-Marie-Tooth (CMT) depends on the dedicated commitment of all stakeholders within our CMT community. HNF wishes to thank the following corporate and media partners for their generous aid in supporting HNF’s mission and for joining us in their own efforts to realize a brighter future for everyone with CMT!

Pharnext
Partnering on programs to increase the awareness around CMT disease and support the development of a stronger CMT patient and research community.

Acceleron
A proud annual sponsor of the Patient-Centered CMT summit and supports the development of Patient Reported Outcomes Research as well as educational materials.

NORD
Partnership to develop natural history studies, supported in part by a cooperative agreement with the U.S. Food and Drug Administration (FDA).

Outcome Health
Partnering to help patients and caregivers through technology.

Inspire
Partnering on the development and support of a robust CMT online Community that connects, patients, families, friends and caregivers for support and inspiration.

Acetylon
Partnering for therapy development for CMT2A using HDAC6 inhibitor compounds for testing in preclinical models.

The Mighty
Partnering to spread awareness for Charcot-Marie-Tooth through social media outlets.

Neurology Reviews
A proud sponsor of the Patient-Centered Charcot-Marie-Tooth Summit.

Rare Disease Report
Partnering to increase awareness of CMT among the medical community and a proud media sponsor of the Patient-Centered Charcot-Marie-Tooth Summit.

Invitae
Partnering to increase awareness of the importance of early and accurate diagnosis of the various types of CMT and related inherited neuropathies (INs) and a proud sponsor of the Patient-Centered Charcot-Marie-Tooth Summit.

AANEM
Partnering to develop and offer the first-ever Charcot-Marie-Tooth (CMT) knowledge assessment test module.

Hannah's Hope Fund
An inherited neuropathy non-profit focused on Giant Axonal Neuropathy, supports HNF’s programs, and co-funds GRIN.